PNC Financial Services Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,546
| Closed | -$30K | – | 4396 |
|
|
2018
Q1 | $30K | Buy |
1,546
+774
| +100% | +$15.2K | ﹤0.01% | 3244 |
|
|
2017
Q4 | $14K | Sell |
772
-120,508
| -99% | -$2.21M | ﹤0.01% | 3573 |
|
|
2017
Q3 | $2.46M | Buy |
121,280
+120,725
| +21,752% | +$2.31M | ﹤0.01% | 950 |
|
|
2017
Q2 | $9K | Buy |
555
+195
| +54% | +$2.88K | ﹤0.01% | 3644 |
|
|
2017
Q1 | $5K | Buy |
360
+284
| +374% | +$3.43K | ﹤0.01% | 3766 |
|
|
2016
Q4 | $1K | Buy |
76
+16
| +27% | +$274 | ﹤0.01% | 3973 |
|
|
2016
Q3 | $1K | Sell |
60
-357
| -86% | -$9.6K | ﹤0.01% | 3930 |
|
|
2016
Q2 | $12K | Sell |
417
-210
| -33% | -$6.84K | ﹤0.01% | 3499 |
|
|
2016
Q1 | $20K | Buy |
627
+15
| +2% | +$527 | ﹤0.01% | 3291 |
|
|
2015
Q4 | $26K | Hold |
612
| – | – | ﹤0.01% | 3176 |
|
|
2015
Q3 | $22K | Buy |
612
+14
| +2% | +$631 | ﹤0.01% | 3343 |
|
|
2015
Q2 | $28K | Sell |
598
-4,422
| -88% | -$210K | ﹤0.01% | 3350 |
|
|
2015
Q1 | $234K | Buy |
5,020
+4,800
| +2,182% | +$191K | ﹤0.01% | 2117 |
|
|
2014
Q4 | $7K | Hold |
220
| – | – | ﹤0.01% | 3470 |
|
|
2014
Q3 | $5K | Hold |
220
| – | – | ﹤0.01% | 3473 |
|
|
2014
Q2 | $7K | Hold |
220
| – | – | ﹤0.01% | 3238 |
|
|
2014
Q1 | $6K | Buy |
+220
| New | +$5.5K | ﹤0.01% | 3216 |
|
|
2013
Q4 | – | Sell |
-139
| Closed | -$3K | – | 3685 |
|
|
2013
Q3 | $3K | Hold |
139
| – | – | ﹤0.01% | 3472 |
|
|
2013
Q2 | $3K | Buy |
+139
| New | +$2.47K | ﹤0.01% | 3358 |
|
PNC Financial Services Group's IPXL Position: Q2 2018 in Review
PNC Financial Services Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,546 shares — an estimated $30K sold.
PNC Financial Services Group first reported a position in IPXL in Q2 2013 and held it in 19 quarters. The position peaked at $2.46M in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- PNC Financial Services Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- PNC Financial Services Group sold 1,546 Impax Laboratories, Inc. shares in Q2 2018, an estimated $30K.
- PNC Financial Services Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 19 quarters.
- PNC Financial Services Group's Impax Laboratories, Inc. position peaked at $2.46M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on PNC Financial Services Group's 13F filing for Q2 2018, filed 10 Aug 2018.